PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 7 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $5,000 | -76.2% | 59,200 | 0.0% | 0.00% | – |
| Q2 2016 | $21,000 | -51.2% | 59,200 | -50.0% | 0.00% | – |
| Q1 2016 | $43,000 | -8.5% | 118,400 | 0.0% | 0.00% | – |
| Q4 2015 | $47,000 | +42.4% | 118,400 | +100.0% | 0.00% | – |
| Q3 2015 | $33,000 | +3.1% | 59,200 | -3.3% | 0.00% | – |
| Q2 2015 | $32,000 | -34.7% | 61,200 | 0.0% | 0.00% | – |
| Q1 2015 | $49,000 | -3.9% | 61,200 | -3.2% | 0.00% | – |
| Q4 2014 | $51,000 | +8.5% | 63,200 | +33.9% | 0.00% | – |
| Q3 2014 | $47,000 | +20.5% | 47,200 | +4.4% | 0.00% | – |
| Q2 2014 | $39,000 | – | 45,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HOME FEDERAL BANK OF TENNESSEE | 100,000 | $2,000 | 0.00% |
| Cutter & CO Brokerage, Inc. | 79,500 | $2,000 | 0.00% |
| Bellwether Investment Group, LLC | 350 | $0 | 0.00% |
| PRINCETON CAPITAL MANAGEMENT LLC | 10,000 | $0 | 0.00% |
| FINANCIAL COUNSELORS INC | 12,600 | $0 | 0.00% |
| GLENMEDE TRUST CO NA | 5,000 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 200 | $0 | 0.00% |
| Focused Wealth Management, Inc | 2,955 | $0 | 0.00% |